OPKO Health Total Liabilities 2010-2024 | OPK

OPKO Health total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
OPKO Health Annual Total Liabilities
(Millions of US $)
2023 $622
2022 $606
2021 $715
2020 $802
2019 $695
2018 $660
2017 $746
2016 $675
2015 $819
2014 $432
2013 $519
2012 $111
2011 $69
2010 $55
2009 $56
OPKO Health Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $853
2024-06-30 $585
2024-03-31 $721
2023-12-31 $622
2023-09-30 $612
2023-06-30 $624
2023-03-31 $618
2022-12-31 $606
2022-09-30 $596
2022-06-30 $651
2022-03-31 $692
2021-12-31 $715
2021-09-30 $652
2021-06-30 $679
2021-03-31 $823
2020-12-31 $802
2020-09-30 $748
2020-06-30 $735
2020-03-31 $684
2019-12-31 $695
2019-09-30 $728
2019-06-30 $747
2019-03-31 $813
2018-12-31 $660
2018-09-30 $692
2018-06-30 $720
2018-03-31 $756
2017-12-31 $746
2017-09-30 $633
2017-06-30 $662
2017-03-31 $653
2016-12-31 $675
2016-09-30 $695
2016-06-30 $758
2016-03-31 $795
2015-12-31 $819
2015-09-30 $1,046
2015-06-30 $699
2015-03-31 $700
2014-12-31 $432
2014-09-30 $408
2014-06-30 $414
2014-03-31 $524
2013-12-31 $519
2013-09-30 $515
2013-06-30 $329
2013-03-31 $334
2012-12-31 $111
2012-09-30 $104
2012-06-30 $79
2012-03-31 $77
2011-12-31 $69
2011-09-30 $49
2011-06-30 $49
2011-03-31 $53
2010-12-31 $55
2010-09-30 $48
2010-06-30 $18
2010-03-31 $31
2009-12-31 $56
2009-09-30 $19
2009-06-30 $21
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.085B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.480B 24.70
Intuitive Surgical (ISRG) United States $196.045B 102.50
Alcon (ALC) Switzerland $42.794B 28.63
Edwards Lifesciences (EW) United States $42.188B 26.79
IQVIA Holdings (IQV) United States $36.777B 20.26
IDEXX Laboratories (IDXX) United States $35.676B 42.01
DexCom (DXCM) United States $30.357B 45.72
Waters (WAT) United States $22.803B 33.72
STERIS (STE) Ireland $21.310B 24.53
SONOVA HOLDING (SONVY) Switzerland $20.157B 0.00
Hologic (HOLX) United States $17.098B 18.47
Fresenius Medical Care AG KGaA (FMS) Germany $14.119B 14.49
Sysmex ADR (SSMXY) Japan $13.255B 0.00
Globus Medical (GMED) United States $11.345B 28.73
Penumbra (PEN) United States $9.105B 89.18
Masimo (MASI) United States $9.091B 43.99
Teleflex (TFX) United States $8.576B 13.68
Glaukos (GKOS) United States $7.735B 0.00
PROCEPT BioRobotics (PRCT) United States $4.949B 0.00
Integer Holdings (ITGR) United States $4.675B 26.50
Veracyte (VCYT) United States $3.420B 102.63
Inari Medical (NARI) United States $2.990B 0.00
LivaNova (LIVN) United Kingdom $2.699B 15.58
Nihon Kohden (NHNKY) Japan $2.361B 17.93
TransMedics (TMDX) United States $2.291B 72.62
Elekta AB (EKTAY) Sweden $2.165B 19.47
Tandem Diabetes Care (TNDM) United States $1.978B 0.00
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
RxSight (RXST) United States $1.739B 0.00
Alphatec Holdings (ATEC) United States $1.365B 0.00
Artivion (AORT) United States $1.243B 82.39
Pulse Biosciences (PLSE) United States $1.215B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.849B 14.43
Paragon 28 (FNA) United States $0.840B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.712B 0.00
IRadimed (IRMD) United States $0.687B 37.11
Mesa Laboratories (MLAB) United States $0.674B 15.88
AxoGen (AXGN) United States $0.656B 0.00
SiBone (SIBN) United States $0.567B 0.00
OrthoPediatrics (KIDS) United States $0.561B 0.00
Pacific Biosciences Of California (PACB) United States $0.556B 0.00
Semler Scientific (SMLR) United States $0.512B 30.12
Treace Medical Concepts (TMCI) United States $0.494B 0.00
Tactile Systems Technology (TCMD) United States $0.439B 23.75
Delcath Systems (DCTH) United States $0.380B 0.00
ClearPoint Neuro (CLPT) United States $0.372B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
CVRx (CVRX) United States $0.327B 0.00
AngioDynamics (ANGO) United States $0.284B 0.00
Inogen (INGN) United States $0.226B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Accuray (ARAY) United States $0.202B 0.00
Sight Sciences (SGHT) United States $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.174B 0.00
Nevro (NVRO) United States $0.157B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.145B 15.49
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
Vicarious Surgical (RBOT) United States $0.095B 0.00
WORK Medical Technology Group (WOK) China $0.092B 0.00
LENSAR (LNSR) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
908 Devices (MASS) United States $0.080B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.054B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.039B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00